Altamira Therapeutics Ltd.: xbrl:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives

Value{"amount": -184967, "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-037199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/0f4d9f1a-fdfb-43a9-8800-e75503231712

History